Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

Checkpoint inhibitors have invigorated cancer immunotherapy research, including cancer vaccination. Classic early phase trial design and endpoints used in developing chemotherapy are not suited for evaluating all forms of cancer treatment. Peripheral T cell response dynamics have demonstrated incons...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Patrick M., Valdera, Franklin A., Smolinsky, Todd R., Adams, Alexandra M., O’Shea, Anne E., Thomas, Katryna K., Van Decar, Spencer, Carpenter, Elizabeth L., Tiwari, Ankur, Myers, John W., Hale, Diane F., Vreeland, Timothy J., Peoples, George E., Stojadinovic, Alex, Clifton, Guy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029975/
https://www.ncbi.nlm.nih.gov/pubmed/36960052
http://dx.doi.org/10.3389/fimmu.2023.1090533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029975/
https://www.ncbi.nlm.nih.gov/pubmed/36960052
http://dx.doi.org/10.3389/fimmu.2023.1090533

Ejemplares similares